Beijing Anjianxi Bio-Medical Technology Co., Ltd.

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Phase Ib Study of Oral R01 Monotherapy in Advanced Solid Tumors	Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, esophageal cancer, esophageal disorder, gastric cancer, gastric neoplasm, neoplasm, squamous cell lung carcinoma, stomach disorder	Not yet recruiting	Phase 1	2026-09-08		NCT07806500

Clinical trials